Drug Trial Radar · NCT00467844
Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
Last checked: Nov 19, 2026Latest source record: Jul 11, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
159
Actual
Start
May 2007
Primary completion
Sep 2008
Study completion Sep 2008
Sponsor
- Lead sponsor
- GTxIndustry
- Sponsor type
- Industry
- First posted
- May 1, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Supportive care
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess if Gtx-024 is effective in increasing lean body mass in subjects with muscle wasting related to cancer.
Conditions
- Cachexia
Interventions
GTx-024Drug
1 mg GTx 024
GTx-024Drug
3 mg GTx-024
PlaceboDrug
Matching Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Efficacy of GTx-024 on Total Body Lean Mass.Time frame: Baseline to Four Months
Locations
52 sites in 2 countries. Site status is shown where the registry gives one.
Alaska Cancer Research and Education Center
Anchorage, Alaska
Highlands Oncology Group
Fayetteville, Arkansas
Compassionate Cancer Care
Corona, California
Compassionate Cancer Care Medical Group
Fountain Valley, California
Pacific Coast Hematology/Oncology Medical Group, Inc.
Fountain Valley, California
Desert Hematology Oncology Medical Group
Rancho Mirage, California
Compassionate Cancer Care
Riverside, California
Penrose Cancer Center
Colorado Springs, Colorado
Dorcy Cancer Center
Pueblo, Colorado
Hartford Hospital Cancer Clinical Research Office
Hartford, Connecticut
Medical Oncology & Hematology, PC
Waterbury, Connecticut
Gainesville Hematology Oncology Associates
Gainesville, Florida
Horizon Institute for Clinical Research
Hollywood, Florida
Hematology Oncology Associates
Lake Worth, Florida
The Radiation Oncology Group
Lake Worth, Florida
Watson Clinic LLP, Center for Cancer Care & Research
Lakeland, Florida
Osler Medical
Melbourne, Florida
Innovative Medical Research of South Florida, Inc.
Miami, Florida
Florida Medical Clinic, PA
Zephyrhills, Florida
Augusta Oncology Associates
Augusta, Georgia
Dublin Hematology and Oncology
Dublin, Georgia
Cancer Center of Kansas
Wichita, Kansas
Kentuckiana Cancer Institute
Louisville, Kentucky
Johns Hopkins University Clinical Trial Unit
Baltimore, Maryland
Center for Cancer & Blood Disorders
Bethesda, Maryland
The Center for Clinical Research WA County Hospital
Hagerstown, Maryland
Newland Medical Center
Southfield, Michigan
The West Clinic
Corinth, Mississippi
West Clinic
Corinth, Mississippi
The West Clinic
Southaven, Mississippi
West Clinic
Southaven, Mississippi
Hematology & Oncology Associates at Bridgeport
Tupelo, Mississippi
Heartland Hematology-Oncology Associates
Kansas City, Missouri
Donald H. Berdeaux, MD, FACP, PC
Great Falls, Montana
Great Falls Clinic, LLP - Clinic Cancer Care
Great Falls, Montana
Creighton University Hematology/Oncology Clinic
Omaha, Nebraska
Cancer Care of Western North Carolina
Ashville, North Carolina
Four Seasons Hospice & Palliative Care
Flat Rock, North Carolina
Hanover Medical Specialists
Wilmington, North Carolina
Gabrail Cancer Center
Canton, Ohio
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.